Back
Xencor Vs. Spyre Therapeutics Industry Stock Comparison
Sell
30
XNCR
Xencor
Last Price:
19.54
Seasonality Move:
5.81%
Sell
39
SYRE
Spyre Therapeutics
Last Price:
25.33
Seasonality Move:
49.76%
Sell
30
Xencor (XNCR)
is a Sell
Is Xencor a Buy, Sell or Hold?
- The current Xencor [XNCR] share price is $19.52. The Score for XNCR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- XNCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $25.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
XNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.46 | Sell |
| Relative Strength Index (14 RSI): | 30.37 | Sell |
| Chaikin Money Flow: | -594307 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.24 - 23.82) | Sell |
| Bollinger Bands (100): | (19.93 - 23.79) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 31.35 | Sell |
| Chaikin Money Flow: | -1780910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.05 - 37.75) | Sell |
| Bollinger Bands (100): | (27.4 - 39.18) | Sell |
XNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.36 | Sell |
| 20-day SMA: | 22.74 | Sell |
| 50-day SMA: | 21.8 | Sell |
| 200-day SMA: | 20.77 | Sell |
| 8-day EMA: | 21.27 | Sell |
| 20-day EMA: | 22.06 | Sell |
| 50-day EMA: | 22.11 | Sell |
| 200-day EMA: | 22.09 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.63 | Sell |
| 20-day SMA: | 34.16 | Sell |
| 50-day SMA: | 35.1 | Sell |
| 200-day SMA: | 24.22 | Buy |
| 8-day EMA: | 32.34 | Sell |
| 20-day EMA: | 33.91 | Sell |
| 50-day EMA: | 34.32 | Sell |
| 200-day EMA: | 27.18 | Sell |
Xencor Earnings Growth & XNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.00 per share, a decrease this year of $1.26 per share, and an increase next year of $0.84 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Xencor Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||